ClinicalTrials.Veeva

Menu

Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients

D

Dental Innovation Foundation Under Royal Patronage

Status

Completed

Conditions

Cancer of Head and Neck
Radiation-induced Xerostomia
Cancer
Dry Mouth

Treatments

Other: Gel-based artificial saliva

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine whether continuous use of edible, gel-based artificial saliva in cancer patients with dry mouth problems will reduce signs and symptoms of dry mouth and improve quality of patients' saliva.

Enrollment

25 patients

Sex

All

Ages

35 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • cancer patients who receive/ had received radiotherapy and/or chemotherapy and have dry mouth problems

Exclusion criteria

  • mucositis more than grade 1
  • cannot perform oral intake of gel-based artificial saliva eg. aspirate

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

25 participants in 1 patient group

Gel-based artificial saliva
Experimental group
Description:
Continuous oral intake of edible gel-based artificial saliva (30-50 ml/day) for four weeks
Treatment:
Other: Gel-based artificial saliva

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems